Morgan Stanley Baudax Bio, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.26 - $0.87 $1,176 - $3,937	4,526 Added 526.28%	5,386 $1,000
Q2 2022 Oct 27, 2022	SELL	$0.68 - $1.87 $310 - $854	-457 Reduced 34.7%	860 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.68 - $1.87 $310 - $854	-457 Reduced 34.7%	860 $1,000
Q1 2022 Oct 27, 2022	BUY	$1.58 - $8.47 $722 - $3,870	457 Added 53.14%	1,317 $2,000
Q1 2022 May 13, 2022	BUY	$1.58 - $8.47 $2,080 - $11,154	1,317 New	1,317 $2,000

Ticker BXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,003,700
Market Cap $200K
Description
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.